Patents by Inventor Terence Seward Baker

Terence Seward Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY MOLECULES WHICH BIND IL-17A AND IL-17F
    Publication number: 20150218271
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 6, 2015
    Inventors: Ralph Adams, Terence Seward Baker, Alastair David Griffiths Lawson
  • ANTIBODIES TO ION CHANNELS
    Publication number: 20150203571
    Abstract: An anti-E1 ion channel antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Application
    Filed: November 19, 2014
    Publication date: July 23, 2015
    Inventors: Karen Margrete Miller, Marc Roger De Ryck, Christian Gilbert J. Wolff, Alastair David Griffiths Lawson, Helene Margaret Finney, Terence Seward Baker
  • Method to generate antibodies to ion channels
    Patent number: 9067995
    Abstract: The present invention provides a method for generating a functionally modifying antibody to an ion channel comprising immunizing a host with a cyclic peptide comprising at least part of an extracellular sequence of said ion channel.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: June 30, 2015
    Assignee: UCB PHARMA S.A.
    Inventor: Terence Seward Baker
  • DNA encoding antibody molecules which bind IL-17A and IL-17F
    Patent number: 9034600
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: May 19, 2015
    Assignee: UCB Biopharma SPRL
    Inventors: Ralph Adams, Terence Seward Baker, Alastair David Griffiths Lawson
  • DNA encoding function modifying Na1.7 antibodies
    Patent number: 8986954
    Abstract: A Nav1.7 binding entity that after binding functionally modifies the activity of the ion channel, in particular an anti-Nav1.7 antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: March 24, 2015
    Assignee: UCB Pharma S.A.
    Inventors: Helene Margaret Finney, Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff
  • Antibodies to the E1 extracellular loop of ion channels
    Patent number: 8926977
    Abstract: An anti-E1 ion channel antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: January 6, 2015
    Assignee: UCB Pharma S.A.
    Inventors: Karen Margrete Miller, Marc Roger De Ryck, Christian Gilbert J. Wolff, Alastair David Griffiths Lawson, Helene Margaret Finney, Terence Seward Baker
  • DNA ENCODING FUNCTION MODIFYING NAv1.7 ANTIBODIES
    Publication number: 20140342406
    Abstract: A Nav1.7 binding entity that after binding functionally modifies the activity of the ion channel, in particular an anti-Nav1.7 antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Application
    Filed: May 23, 2014
    Publication date: November 20, 2014
    Applicant: UCB PHARMA S.A.
    Inventors: Helene Margaret Finney, Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J. Wolff
  • Function modifying NAv 1.7 antibodies
    Patent number: 8734798
    Abstract: A Nav1.7 binding entity that after binding functionally modifies the activity of the ion channel, in particular an anti-Nav1.7 antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: May 27, 2014
    Assignee: UCB Pharma S.A.
    Inventors: Helene Margaret Finney, Terence Seward Baker, Alastair David Griffiths Lawson, Karen Margrete Miller, Marc Roger de Ryck, Christian Gilbert J Wolff
  • ANTIBODY MOLECULES WHICH BIND IL-17A AND IL-17F
    Publication number: 20140065674
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: November 8, 2013
    Publication date: March 6, 2014
    Applicant: UCB PHARMA S.A.
    Inventors: RALPH ADAMS, TERENCE SEWARD BAKER, ALASTAIR DAVID GRIFFITHS LAWSON
  • Antibody molecules which bind IL-17A and IL-17F
    Patent number: 8580265
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: November 12, 2013
    Assignee: UCB Pharma S.A.
    Inventors: Ralph Adams, Terence Seward Baker, Alastair David Griffiths Lawson
  • Altered antibodies
    Patent number: 8507654
    Abstract: This invention relates to engineering of antibodies and more specifically provides altered antibodies of the IgG class to which one or more effector molecules are attached. The invention further relates to methods for the production of such conjugated antibodies.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: August 13, 2013
    Assignee: UCB Pharma S.A.
    Inventors: Terence Seward Baker, David Paul Humphreys, Alastair David Griffiths Lawson
  • METHOD TO GENERATE ANTIBODIES TO ION CHANNELS
    Publication number: 20120263727
    Abstract: The present invention provides a method for generating a functionally modifying antibody to an ion channel comprising immunizing a host with a cyclic peptide comprising at least part of an extracellular sequence of said ion channel.
    Type: Application
    Filed: October 27, 2010
    Publication date: October 18, 2012
    Applicant: UCB PHARMA S.A.
    Inventor: Terence Seward Baker
  • METHOD TO GENERATE ANTIBODIES TO ION CHANNELS
    Publication number: 20120263728
    Abstract: The present invention provides a method for generating a functionally modifying antibody to an ion channel comprising immunizing a host with a cyclic peptide comprising at least part of an extracellular sequence of said ion channel.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 18, 2012
    Applicant: UCB Pharma S.A.
    Inventor: Terence Seward Baker
  • ANTIBODIES TO ION CHANNELS
    Publication number: 20120259096
    Abstract: An anti-E1 ion channel antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Application
    Filed: October 27, 2010
    Publication date: October 11, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Karen Margrete Miller, Marc Roger De Ryck, Christian Gilbert J. Wolff, Alastair David Griffiths Lawson, Helene Margaret Finney, Terence Seward Baker
  • ANTIBODY MOLECULES WHICH BIND IL-17A AND IL-17F
    Publication number: 20120183558
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 19, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Ralph Adams, Terence Seward Baker, Alastair David Griffiths Lawson
  • Cross-linked antibodies
    Patent number: 8053564
    Abstract: The present invention provides a compound consisting essentially of the following elements: one or more reactive groups; and two or more cross-linked antibodies or fragments thereof; characterised in that the or each reactive group is suitable for attaching an effector molecule but does not react with any of the antibodies or fragments thereof.
    Type: Grant
    Filed: May 17, 2005
    Date of Patent: November 8, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Terence Seward Baker, Catherine McKay, Timothy John Norman, John Robert Porter
  • FUNCTION MODIFYING NAv 1.7 ANTIBODIES
    Publication number: 20110135662
    Abstract: A Nav1.7 binding entity that after binding functionally modifies the activity of the ion channel, in particular an anti-Nav1.7 antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.
    Type: Application
    Filed: October 27, 2010
    Publication date: June 9, 2011
    Inventors: HELENE MARGARET FINNEY, TERENCE SEWARD BAKER, ALASTAIR DAVID GRIFFITHS LAWSON, KAREN MARGRETE MILLER, MARC ROGER DE RYCK, CHRISTIAN GILBERT J. WOLFF
  • Targeted lipid particles
    Patent number: 7718157
    Abstract: Targeted lipids and lipid particles are described which are assemblies of multipolar lipids, targeting molecules such as antibodies and polyanions. The lipids are of particular use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: May 18, 2010
    Inventors: Terence Seward Baker, Andrew Neil Charles Weir, Catherine Fiona Catterall, Michael Anthony William Eaton, Timothy John Norman, David Parker
  • Lipids
    Patent number: 7531676
    Abstract: Bipolar lipids are described which are able to form complexes with polyanions. The lipids comprise a cationic head linked to a hydrophobic backbone and a hydrophilic tail and are capable of self assembly to form stable complexes in aqueous solutions. The lipids are of particular use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: May 12, 2009
    Assignee: Celltech R & D Limited
    Inventors: Michael Anthony William Eaton, Timothy John Norman, David Parker, Terence Seward Baker, Andrew Neil Charles Weir, Catherine Fiona Catterall
  • Cross-Linked Antibodies
    Publication number: 20080160017
    Abstract: The present invention provides a compound consisting essentially of the following elements: one or more reactive groups; and two or more cross-linked antibodies or fragments thereof; characterised in that the or each reactive group is suitable for attaching an effector molecule but does not react with any of the antibodies or fragments thereof.
    Type: Application
    Filed: May 17, 2005
    Publication date: July 3, 2008
    Inventors: Terence Seward Baker, Catherine McKay, Timothy John Norman, John Robert Porter